MENU
CERO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
CERO Therapeutics Holdings (CERO) Ownership - Who owns CERO Therapeutics Holdings?
CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T cell therapeutics for the treatment of cancer... Show more
Profile
Industry
N/A
Address
201 Haskings Way
Phone
+1 215 731-9450
Employees
9
Web
https://www.cero.bio
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
4.95M
P/E Ratio
N/A
Total Cash
5.2M
Projected Growth
N/A
Total Debt
1.37M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
10.08
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
CERO
Capitalization
4.95M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
5.2M
Total Cash/Share
10.08
Total Debt
1.37M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
N/A
ROE
N/A
Book Value
-2.76M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
517
Current Ratio
0.73
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
N/A
Shares Held By Institutions
N/A
Shares Outstanding - Current
516K
Total Liabilities
N/A
Total Volume MTD
N/A
Value
1
Gain YTD
-92.042
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
201 Haskings Way
Phone
+1 215 731-9450
Employees
9
Web
https://www.cero.bio